National Institute for Health and Care Excellence (NICE)
- Empagliflozin in combination therapy for treating type 2 diabetes.
- Maintaining a healthy weight and preventing excess weight gain among adults and children.
- Medicines optimisation: the safe and effective use of medicines to enable the best possible outcomes.
- Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndrome.